239 related articles for article (PubMed ID: 32411759)
21. Diagnostic Accuracy of Serum/Plasma Circular RNAs and the Combination of Circular RNAs and α-Fetoprotein for Detecting Hepatocellular Carcinoma: A Meta-Analysis.
Nie G; Peng D; Li B; Lu J; Cai Y; Xiong X; Cheng N
Front Genet; 2021; 12():722208. PubMed ID: 34659344
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic value of serum Golgi protein-73 (GP73) combined with AFP-L3% in hepatocellular carcinoma: a meta-analysis].
Shi M; Huang Z; Yang Y; Zhao B
Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):189-93. PubMed ID: 25938831
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
Jia X; Liu J; Gao Y; Huang Y; Du Z
Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
[TBL] [Abstract][Full Text] [Related]
24. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
25. AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis.
Zhou JM; Wang T; Zhang KH
Medicine (Baltimore); 2021 Oct; 100(43):e27673. PubMed ID: 34713864
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
Wang X; Zhang Y; Yang N; He H; Tao X; Kou C; Jiang J
Biomed Res Int; 2020; 2020():5087643. PubMed ID: 33015170
[TBL] [Abstract][Full Text] [Related]
27. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
[TBL] [Abstract][Full Text] [Related]
28. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma.
Pang BY; Leng Y; Wang X; Wang YQ; Jiang LH
Ann Med; 2023 Dec; 55(1):42-61. PubMed ID: 36476015
[TBL] [Abstract][Full Text] [Related]
29. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis.
Zhang X; Wu LN; Li XQ; Luo X; Liu SW; Zhang L; Nawaz S; Ma LN; Ding XC
BMC Gastroenterol; 2023 Mar; 23(1):85. PubMed ID: 36964524
[TBL] [Abstract][Full Text] [Related]
30. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
31. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
32. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
Ali OM; El Amin HA; Sharkawy YL; Mohamed Ali AA; Kholef EFM; Elsewify WAE
Int J Gen Med; 2020; 13():193-200. PubMed ID: 32547160
[TBL] [Abstract][Full Text] [Related]
33. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma.
Jiao C; Cui L; Piao J; Qi Y; Yu Z
J Cancer Res Ther; 2018; 14(6):1239-1244. PubMed ID: 30488837
[TBL] [Abstract][Full Text] [Related]
35. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
Hussein TD
Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
[TBL] [Abstract][Full Text] [Related]
36. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
37. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis.
Eissa M; Awad S; Barakat S; Saleh A; Rozaik S
Med J Armed Forces India; 2021 Jul; 77(3):331-336. PubMed ID: 34305287
[TBL] [Abstract][Full Text] [Related]
38. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Lin S; Hu S; Ran Y; Wu F
Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size.
Liu A; Li Y; Shen L; Shen L; Li Z
Aging (Albany NY); 2022 Mar; 14(6):2645-2664. PubMed ID: 35307694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]